Nifty

:

22620.40

Sensex

:

74398.48

50.05 (0.22%)
59.04 (0.08%)

Login

Nifty
Sensex

:
:

22620.40
74398.48

50.05 (0.22%)
59.04 (0.08%)

Nectar Lifesciences Ltd.

Pharmaceuticals & Drugs - Global

Rating :

43/99

BSE: 532649 | NSE: NECLIFE

Watchlist

NSE BSE

34.25

25-Apr-2024

Open
High
Low
Previous Close

34.00
34.60
33.95
34.60

Volume
Traded Value (lacs)
52 Week High
52 Week Low

182158
62.47
45.70
16.50

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

765.85
94.80
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,427.09
N/A
0.72

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-0.72
-11.35
-0.43

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-15.57
-27.47
-12.18

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-30.89

P:E (Median)

8 Years
5 Years
3 Years

8.47
-
-

P:BV (Average)

8 Years
5 Years
3 Years

0.55
0.47
0.56

EV:EBITDA (Average)

8 Years
5 Years
3 Years

7.77
8.75
10.82

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 452.17 344.13 31.40% 397.96 388.65 2.40% 394.12 403.02 -2.21% 388.81 476.23 -18.36%
Expenses 409.98 342.68 19.64% 371.10 396.05 -6.30% 358.58 361.18 -0.72% 369.04 427.08 -13.59%
EBITDA 42.19 1.44 2,829.86% 26.87 -7.40 - 35.54 41.85 -15.08% 19.77 49.15 -59.78%
EBIDTM 8.22% 0.37% 5.98% -1.65% 7.88% 8.98% 4.42% 8.98%
Other Income 0.48 13.24 -96.37% 10.61 10.71 -0.93% 0.47 0.36 30.56% 17.93 0.52 3,348.08%
Interest 24.84 17.46 42.27% 20.52 20.99 -2.24% 17.62 21.37 -17.55% 19.66 17.43 12.79%
Depreciation 15.37 14.78 3.99% 15.31 14.79 3.52% 15.33 14.69 4.36% 14.85 14.26 4.14%
PBT 2.46 -17.56 - 1.64 -32.47 - 3.06 6.15 -50.24% 3.19 17.98 -82.26%
Tax 0.89 -8.27 - 0.63 -10.00 - 1.24 2.21 -43.89% -2.17 6.32 -
PAT 1.56 -9.29 - 1.02 -22.47 - 1.82 3.94 -53.81% 5.36 11.66 -54.03%
PATM 0.30% -2.40% 0.23% -5.02% 0.40% 0.84% 1.20% 2.13%
EPS 0.09 -0.52 - 0.06 -1.26 - 0.10 0.22 -54.55% 0.30 0.65 -53.85%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 452.17 344.13 31.40% 397.96 388.65 2.40% 394.12 403.02 -2.21% 388.81 476.23 -18.36%
Expenses 409.98 342.68 19.64% 371.10 396.04 -6.30% 358.58 361.22 -0.73% 370.73 427.08 -13.19%
EBITDA 42.19 1.45 2,809.66% 26.87 -7.40 - 35.54 41.81 -15.00% 18.09 49.15 -63.19%
EBIDTM 8.22% 0.37% 5.98% -1.65% 7.88% 8.97% 4.05% 8.98%
Other Income 0.48 13.24 -96.37% 10.61 10.71 -0.93% 0.47 0.36 30.56% 17.93 0.52 3,348.08%
Interest 24.84 17.46 42.27% 20.52 20.99 -2.24% 17.62 21.37 -17.55% 19.66 17.43 12.79%
Depreciation 15.37 14.78 3.99% 15.31 14.79 3.52% 15.33 14.69 4.36% 14.85 14.26 4.14%
PBT 2.46 -17.56 - 1.64 -32.47 - 3.06 6.11 -49.92% 1.50 17.98 -91.66%
Tax 0.89 -8.27 - 0.63 -10.00 - 1.24 2.21 -43.89% -2.17 6.32 -
PAT 1.56 -9.29 - 1.02 -22.47 - 1.82 3.90 -53.33% 3.68 11.66 -68.44%
PATM 0.30% -2.40% 0.23% -5.02% 0.40% 0.84% 0.82% 2.13%
EPS 0.07 -0.41 - 0.05 -1.00 - 0.08 0.17 -52.94% 0.16 0.52 -69.23%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 1,633.06 1,523.67 1,668.23 1,541.82 2,362.80 2,784.93 1,875.53 1,643.34 1,676.32 1,643.64 1,638.31 Net Sales Growth 1.30% -8.67% 8.20% -34.75% -15.16% 48.49% 14.13% -1.97% 1.99% 0.33% Cost Of Goods Sold 1,184.84 1,159.20 1,222.29 1,155.62 1,857.58 2,221.15 1,366.48 1,154.17 1,174.68 1,141.33 1,154.68 Gross Profit 448.22 364.47 445.94 386.21 505.22 563.78 509.05 489.17 501.64 502.31 483.63 GP Margin 27.45% 23.92% 26.73% 25.05% 21.38% 20.24% 27.14% 29.77% 29.93% 30.56% 29.52% Total Expenditure 1,508.70 1,468.95 1,509.42 1,440.26 2,144.83 2,521.03 1,639.49 1,419.13 1,437.49 1,376.73 1,350.44 Power & Fuel Cost - 127.39 101.41 84.63 92.72 103.47 91.85 75.44 87.89 79.60 66.10 % Of Sales - 8.36% 6.08% 5.49% 3.92% 3.72% 4.90% 4.59% 5.24% 4.84% 4.03% Employee Cost - 75.13 71.91 70.55 78.19 76.54 74.65 75.54 78.38 58.93 47.97 % Of Sales - 4.93% 4.31% 4.58% 3.31% 2.75% 3.98% 4.60% 4.68% 3.59% 2.93% Manufacturing Exp. - 45.32 45.56 44.64 46.88 50.38 52.90 53.32 39.56 37.05 33.57 % Of Sales - 2.97% 2.73% 2.90% 1.98% 1.81% 2.82% 3.24% 2.36% 2.25% 2.05% General & Admin Exp. - 19.31 18.32 20.73 19.94 21.77 23.02 20.05 20.34 21.60 22.03 % Of Sales - 1.27% 1.10% 1.34% 0.84% 0.78% 1.23% 1.22% 1.21% 1.31% 1.34% Selling & Distn. Exp. - 41.28 48.03 50.79 45.75 44.68 28.72 39.00 35.24 35.25 24.71 % Of Sales - 2.71% 2.88% 3.29% 1.94% 1.60% 1.53% 2.37% 2.10% 2.14% 1.51% Miscellaneous Exp. - 1.32 1.90 13.31 3.76 3.04 1.87 1.61 1.41 2.97 24.71 % Of Sales - 0.09% 0.11% 0.86% 0.16% 0.11% 0.10% 0.10% 0.08% 0.18% 0.08% EBITDA 124.37 54.72 158.81 101.56 217.97 263.90 236.04 224.21 238.83 266.91 287.87 EBITDA Margin 7.62% 3.59% 9.52% 6.59% 9.23% 9.48% 12.59% 13.64% 14.25% 16.24% 17.57% Other Income 29.49 43.18 11.32 11.38 4.36 6.04 6.04 22.67 5.78 20.00 12.53 Interest 82.64 79.48 78.81 112.03 125.82 148.13 115.20 117.41 123.31 125.59 137.99 Depreciation 60.86 59.12 56.97 60.25 60.77 63.26 64.31 62.25 57.39 76.56 84.19 PBT 10.35 -40.69 34.35 -59.34 35.74 58.55 62.57 67.21 63.91 84.75 78.22 Tax 0.59 -18.24 9.03 -11.50 5.68 11.22 10.41 12.08 9.59 18.49 16.14 Tax Rate 5.70% 44.83% 26.29% 13.58% 15.89% 19.16% 16.64% 17.97% 15.01% 21.82% 20.63% PAT 9.76 -22.46 25.32 -73.15 30.06 47.33 52.15 55.13 54.33 66.26 62.08 PAT before Minority Interest 9.76 -22.46 25.32 -73.15 30.06 47.33 52.15 55.13 54.33 66.26 62.08 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 0.60% -1.47% 1.52% -4.74% 1.27% 1.70% 2.78% 3.35% 3.24% 4.03% 3.79% PAT Growth 160.40% - - - -36.49% -9.24% -5.41% 1.47% -18.00% 6.73% EPS 0.55 -1.26 1.42 -4.10 1.69 2.65 2.92 3.09 3.05 3.72 3.48

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 1,633.06 1,523.67 1,668.83 1,543.30 2,366.38 2,782.86 1,876.26 1,643.70 1,675.69 1,643.64 1,638.31 Net Sales Growth 1.30% -8.70% 8.13% -34.78% -14.97% 48.32% 14.15% -1.91% 1.95% 0.33% Cost Of Goods Sold 1,184.93 1,159.29 1,223.13 1,157.12 1,858.61 2,217.71 1,367.01 1,154.31 1,174.12 1,141.33 1,154.68 Gross Profit 448.13 364.38 445.70 386.19 507.77 565.16 509.25 489.39 501.57 502.31 483.63 GP Margin 27.44% 23.91% 26.71% 25.02% 21.46% 20.31% 27.14% 29.77% 29.93% 30.56% 29.52% Total Expenditure 1,510.39 1,470.66 1,510.29 1,441.84 2,146.68 2,518.70 1,640.10 1,419.29 1,436.94 1,376.73 1,350.44 Power & Fuel Cost - 127.39 101.41 84.63 92.72 103.47 91.85 75.44 87.89 79.60 66.10 % Of Sales - 8.36% 6.08% 5.48% 3.92% 3.72% 4.90% 4.59% 5.25% 4.84% 4.03% Employee Cost - 75.13 71.91 70.59 78.19 76.55 74.65 75.54 78.38 58.93 47.97 % Of Sales - 4.93% 4.31% 4.57% 3.30% 2.75% 3.98% 4.60% 4.68% 3.59% 2.93% Manufacturing Exp. - 45.32 45.56 44.64 46.88 50.38 52.90 53.32 39.56 37.05 33.57 % Of Sales - 2.97% 2.73% 2.89% 1.98% 1.81% 2.82% 3.24% 2.36% 2.25% 2.05% General & Admin Exp. - 19.35 18.36 20.74 20.15 21.82 23.02 20.07 20.36 21.60 22.03 % Of Sales - 1.27% 1.10% 1.34% 0.85% 0.78% 1.23% 1.22% 1.22% 1.31% 1.34% Selling & Distn. Exp. - 42.87 48.03 50.82 46.37 45.66 28.72 39.00 35.24 35.25 24.71 % Of Sales - 2.81% 2.88% 3.29% 1.96% 1.64% 1.53% 2.37% 2.10% 2.14% 1.51% Miscellaneous Exp. - 1.32 1.90 13.31 3.76 3.12 1.95 1.61 1.41 2.97 24.71 % Of Sales - 0.09% 0.11% 0.86% 0.16% 0.11% 0.10% 0.10% 0.08% 0.18% 0.08% EBITDA 122.69 53.01 158.54 101.46 219.70 264.16 236.16 224.41 238.75 266.91 287.87 EBITDA Margin 7.51% 3.48% 9.50% 6.57% 9.28% 9.49% 12.59% 13.65% 14.25% 16.24% 17.57% Other Income 29.49 43.18 11.32 11.38 4.36 6.04 6.04 22.67 5.78 20.00 12.53 Interest 82.64 79.49 78.81 112.03 125.83 148.13 115.20 117.41 123.31 125.59 137.99 Depreciation 60.86 59.12 56.97 60.25 60.77 63.26 64.31 62.25 57.39 76.56 84.19 PBT 8.66 -42.42 34.08 -59.45 37.47 58.82 62.68 67.42 63.83 84.75 78.23 Tax 0.59 -18.24 9.03 -11.50 5.68 11.22 10.41 12.08 9.59 18.49 16.14 Tax Rate 6.81% 43.00% 26.50% 13.57% 15.16% 19.08% 16.61% 17.92% 15.02% 21.82% 20.63% PAT 8.08 -24.18 25.05 -73.26 31.79 47.60 52.27 55.34 54.24 66.26 62.09 PAT before Minority Interest 8.08 -24.18 25.05 -73.26 31.79 47.60 52.27 55.34 54.24 66.26 62.09 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 0.49% -1.59% 1.50% -4.75% 1.34% 1.71% 2.79% 3.37% 3.24% 4.03% 3.79% PAT Growth 149.88% - - - -33.21% -8.93% -5.55% 2.03% -18.14% 6.72% EPS 0.45 -1.36 1.40 -4.11 1.78 2.67 2.93 3.10 3.04 3.72 3.48

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 1,064.60 1,086.86 1,060.73 1,134.61 1,104.64 1,058.63 1,006.73 954.27 957.95 927.06 Share Capital 22.43 22.43 22.43 22.43 22.43 22.43 22.43 22.43 22.43 22.43 Total Reserves 1,042.17 1,064.44 1,038.31 1,112.18 1,082.21 1,036.20 984.30 931.85 935.52 904.64 Non-Current Liabilities 213.12 296.66 126.79 249.67 299.91 355.94 295.66 362.35 396.92 340.94 Secured Loans 213.16 280.80 127.46 120.00 164.40 218.21 161.20 243.44 264.36 222.59 Unsecured Loans 13.31 10.28 0.78 1.48 1.19 1.87 2.60 1.96 1.17 0.75 Long Term Provisions 6.45 6.39 7.74 8.20 9.36 9.07 8.49 6.91 6.01 4.90 Current Liabilities 890.93 1,003.75 1,187.39 1,247.89 1,299.23 1,309.32 1,278.66 1,239.95 1,155.60 1,126.07 Trade Payables 318.75 376.65 342.15 527.14 483.00 539.42 528.10 496.78 455.58 440.06 Other Current Liabilities 111.40 122.63 131.63 95.44 170.40 123.40 106.88 107.95 90.50 86.72 Short Term Borrowings 458.91 502.77 712.00 619.71 635.97 634.08 630.34 627.24 595.30 579.84 Short Term Provisions 1.86 1.70 1.61 5.59 9.87 12.41 13.34 7.98 14.22 19.45 Total Liabilities 2,168.65 2,387.27 2,374.91 2,632.17 2,703.78 2,723.89 2,581.05 2,556.57 2,510.47 2,394.07 Net Block 661.97 723.10 771.89 784.85 824.82 852.35 881.24 905.58 933.73 947.54 Gross Block 1,557.96 1,562.95 1,555.70 1,508.82 1,490.49 1,456.36 1,363.67 1,383.66 1,451.42 1,341.15 Accumulated Depreciation 895.99 839.85 783.81 723.97 665.68 604.00 482.43 478.08 517.69 393.61 Non Current Assets 937.47 1,033.52 1,137.34 1,018.49 1,036.29 1,063.54 1,085.38 1,092.25 1,105.54 1,156.72 Capital Work in Progress 77.78 85.10 98.63 115.00 99.55 99.79 102.11 99.35 91.31 122.26 Non Current Investment 0.24 0.57 0.57 0.57 0.60 0.60 0.60 0.60 0.15 0.05 Long Term Loans & Adv. 9.31 9.76 12.17 115.07 108.33 104.19 96.90 82.24 80.34 86.87 Other Non Current Assets 188.16 214.99 254.08 2.99 2.99 6.61 4.53 4.47 0.00 0.00 Current Assets 1,231.18 1,353.75 1,237.57 1,613.68 1,667.49 1,660.35 1,495.67 1,464.33 1,369.02 1,237.34 Current Investments 0.31 0.46 0.46 0.17 0.51 0.51 0.41 0.52 0.44 0.31 Inventories 672.60 659.77 586.97 975.13 914.53 859.43 854.13 836.06 790.98 758.43 Sundry Debtors 279.61 446.98 374.59 396.87 561.38 612.12 500.43 492.24 446.50 376.65 Cash & Bank 17.57 17.74 25.43 21.23 20.58 8.91 12.81 36.41 33.38 9.98 Other Current Assets 261.08 67.05 51.67 70.52 170.50 179.38 127.89 99.09 97.73 91.97 Short Term Loans & Adv. 165.03 161.75 198.45 149.76 98.69 124.56 74.01 67.55 84.61 69.02 Net Current Assets 340.25 350.00 50.17 365.79 368.26 351.03 217.01 224.38 213.42 111.27 Total Assets 2,168.65 2,387.27 2,374.91 2,632.17 2,703.78 2,723.89 2,581.05 2,556.58 2,510.47 2,394.07

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 1,064.59 1,087.90 1,062.03 1,136.13 1,105.16 1,058.66 1,006.68 954.08 957.95 927.06 Share Capital 22.43 22.43 22.43 22.43 22.43 22.43 22.43 22.43 22.43 22.43 Total Reserves 1,042.17 1,065.48 1,039.60 1,113.70 1,082.73 1,036.23 984.25 931.65 935.52 904.64 Non-Current Liabilities 213.12 296.29 126.41 249.29 299.92 355.84 295.58 362.30 396.92 340.94 Secured Loans 213.16 280.80 127.46 120.00 164.40 218.21 161.20 243.44 264.36 222.59 Unsecured Loans 13.31 10.28 0.78 1.48 1.19 1.87 2.60 1.96 1.17 0.75 Long Term Provisions 6.45 6.39 7.74 8.20 9.36 9.07 8.49 6.91 6.01 4.90 Current Liabilities 890.93 1,003.83 1,187.39 1,247.89 1,299.91 1,309.32 1,278.66 1,239.95 1,155.60 1,126.07 Trade Payables 318.75 376.65 342.15 527.14 483.67 539.42 528.10 496.78 455.58 440.06 Other Current Liabilities 111.40 122.71 131.63 95.44 170.40 123.40 106.88 107.95 90.50 86.72 Short Term Borrowings 458.91 502.77 712.00 619.71 635.97 634.08 630.34 627.24 595.30 579.84 Short Term Provisions 1.86 1.70 1.61 5.59 9.87 12.41 13.34 7.98 14.22 19.45 Total Liabilities 2,168.64 2,388.02 2,375.83 2,633.31 2,704.99 2,723.82 2,580.92 2,556.33 2,510.47 2,394.07 Net Block 661.97 723.10 771.89 784.85 824.82 852.35 881.24 905.58 933.73 947.54 Gross Block 1,557.96 1,562.95 1,555.70 1,508.82 1,490.49 1,456.36 1,363.67 1,383.66 1,451.42 1,341.15 Accumulated Depreciation 895.99 839.85 783.81 723.97 665.68 604.00 482.43 478.08 517.69 393.61 Non Current Assets 937.46 1,033.18 1,137.01 1,018.15 1,035.96 1,063.21 1,085.05 1,091.92 1,105.54 1,156.72 Capital Work in Progress 77.78 85.10 98.63 115.00 99.55 99.79 102.11 99.35 91.31 122.26 Non Current Investment 0.24 0.24 0.24 0.24 0.27 0.27 0.27 0.27 0.15 0.05 Long Term Loans & Adv. 9.31 9.76 12.17 115.07 108.33 104.19 96.90 82.24 80.34 86.87 Other Non Current Assets 188.16 214.99 254.08 2.99 2.99 6.61 4.53 4.47 0.00 0.00 Current Assets 1,231.18 1,354.85 1,238.83 1,615.16 1,669.03 1,660.61 1,495.86 1,464.42 1,369.02 1,237.34 Current Investments 0.31 0.46 0.46 0.17 0.51 0.51 0.41 0.52 0.44 0.31 Inventories 672.60 659.86 587.89 977.55 917.97 859.43 854.65 836.71 790.98 758.43 Sundry Debtors 279.61 446.98 374.83 395.87 558.73 611.97 499.73 491.45 446.50 376.65 Cash & Bank 17.58 17.81 25.54 21.29 21.33 9.31 13.18 36.65 33.38 9.98 Other Current Assets 261.08 67.05 51.67 70.52 170.50 179.38 127.89 99.09 97.73 91.97 Short Term Loans & Adv. 165.03 162.69 198.45 149.76 98.69 124.56 74.01 67.55 84.61 69.02 Net Current Assets 340.26 351.02 51.44 367.27 369.13 351.29 217.20 224.47 213.42 111.27 Total Assets 2,168.64 2,388.03 2,375.84 2,633.31 2,704.99 2,723.82 2,580.91 2,556.34 2,510.47 2,394.07

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 133.37 95.04 21.33 285.65 238.89 65.14 198.62 168.91 144.41 254.87 PBT -40.69 34.35 -84.65 35.74 58.55 62.57 67.21 64.83 84.75 78.22 Adjustment 97.08 125.44 148.28 187.58 206.90 175.74 158.85 174.16 185.24 212.94 Changes in Working Capital 76.98 -64.75 -38.69 71.65 -13.00 -160.56 -20.26 -61.52 -119.29 -16.31 Cash after chg. in Working capital 133.37 95.04 24.94 294.98 252.45 77.75 205.80 177.47 150.70 274.85 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 -3.61 -9.33 -13.56 -12.62 -7.17 -8.56 -6.29 -19.98 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 52.03 16.64 -28.62 -33.13 -26.13 -29.43 -18.10 -77.21 -59.53 -89.99 Net Fixed Assets 12.31 6.28 -30.51 -33.78 -33.89 -90.37 17.23 59.72 -79.32 -101.53 Net Investments 0.48 0.00 -0.29 0.37 0.00 -0.10 0.11 -0.53 -0.23 0.01 Others 39.24 10.36 2.18 0.28 7.76 61.04 -35.44 -136.40 20.02 11.53 Cash from Financing Activity -185.57 -119.38 11.49 -251.87 -201.09 -39.60 -204.12 -88.68 -61.47 -161.14 Net Cash Inflow / Outflow -0.17 -7.70 4.20 0.65 11.67 -3.90 -23.60 3.03 23.40 3.74 Opening Cash & Equivalents 17.74 25.43 21.23 20.58 8.91 12.81 36.41 33.38 9.98 6.24 Closing Cash & Equivalent 17.57 17.74 25.43 21.23 20.58 8.91 12.81 36.41 33.38 9.98

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 133.65 95.00 21.38 284.96 239.24 65.17 198.76 168.82 144.41 254.87 PBT -42.42 34.08 -84.77 37.47 58.82 62.68 67.42 64.74 84.75 78.22 Adjustment 98.15 125.47 150.40 186.46 207.17 175.82 158.85 174.16 185.24 212.94 Changes in Working Capital 77.92 -64.54 -40.54 70.36 -13.19 -160.72 -20.34 -61.52 -119.29 -16.31 Cash after chg. in Working capital 133.65 95.00 25.09 294.29 252.79 77.79 205.93 177.38 150.70 274.85 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 -3.71 -9.33 -13.56 -12.62 -7.17 -8.56 -6.29 -19.98 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 51.70 16.64 -28.62 -33.13 -26.13 -29.43 -18.10 -76.88 -59.53 -89.99 Net Fixed Assets 12.31 6.28 -30.51 -33.78 -33.89 -90.37 17.23 59.72 -79.32 -101.53 Net Investments 0.48 0.00 -0.29 0.37 0.00 -0.10 0.11 -0.53 -0.23 0.01 Others 38.91 10.36 2.18 0.28 7.76 61.04 -35.44 -136.07 20.02 11.53 Cash from Financing Activity -185.58 -119.38 11.49 -251.87 -201.09 -39.60 -204.12 -88.68 -61.47 -161.14 Net Cash Inflow / Outflow -0.23 -7.73 4.25 -0.03 12.02 -3.87 -23.47 3.27 23.40 3.74 Opening Cash & Equivalents 17.81 25.54 21.29 21.33 9.31 13.18 36.65 33.38 9.98 6.24 Closing Cash & Equivalent 17.58 17.81 25.54 21.29 21.33 9.31 13.18 36.65 33.38 9.98

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 47.47 48.46 47.30 50.59 49.26 47.21 44.89 42.55 41.11 41.34 ROA -0.99% 1.06% -2.92% 1.13% 1.74% 1.97% 2.15% 2.14% 2.70% 2.66% ROE -2.09% 2.36% -6.66% 2.68% 4.38% 5.05% 5.62% 5.79% 7.17% 6.92% ROCE 2.06% 5.79% 1.41% 8.24% 10.28% 9.12% 9.71% 9.95% 11.58% 12.24% Fixed Asset Turnover 1.12 1.23 1.15 1.76 2.11 1.48 1.27 1.27 1.25 1.33 Receivable days 75.92 77.89 79.89 66.26 68.75 97.04 103.90 95.54 85.98 77.54 Inventory Days 139.22 118.20 161.77 130.67 103.93 149.46 176.91 165.59 161.85 153.20 Payable days 109.48 107.32 137.28 82.41 68.82 113.92 128.03 119.13 113.39 105.76 Cash Conversion Cycle 105.66 88.77 104.38 114.51 103.87 132.58 152.78 141.99 134.44 124.98 Total Debt/Equity 0.71 0.79 0.85 0.69 0.82 0.90 0.87 1.01 1.00 0.93 Interest Cover 0.49 1.44 0.24 1.28 1.40 1.54 1.57 1.52 1.67 1.57

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 47.47 48.51 47.36 50.66 49.28 47.21 44.89 42.54 41.11 41.34 ROA -1.06% 1.05% -2.93% 1.19% 1.75% 1.97% 2.15% 2.14% 2.70% 2.66% ROE -2.25% 2.33% -6.67% 2.84% 4.40% 5.06% 5.64% 5.78% 7.17% 6.92% ROCE 1.97% 5.77% 1.41% 8.32% 10.29% 9.13% 9.73% 9.95% 11.58% 12.24% Fixed Asset Turnover 1.12 1.23 1.15 1.76 2.11 1.48 1.27 1.26 1.25 1.33 Receivable days 75.92 77.89 79.75 65.92 68.64 96.93 103.72 95.49 85.98 77.54 Inventory Days 139.23 118.26 161.98 130.89 104.21 149.46 176.99 165.71 161.85 153.20 Payable days 109.47 107.25 137.11 82.45 68.84 113.92 128.03 119.13 113.39 105.76 Cash Conversion Cycle 105.68 88.90 104.62 114.37 104.01 132.47 152.69 142.07 134.44 124.98 Total Debt/Equity 0.71 0.79 0.85 0.69 0.82 0.90 0.87 1.01 1.00 0.93 Interest Cover 0.47 1.43 0.24 1.30 1.40 1.54 1.57 1.52 1.67 1.57

Top Investors:

nsr direct pe mauritius llc

ingain traders, llc

investor education and protection fund (iepf)

Annual Reports:

News Update:

Nectar Lifesciences - Quarterly Results
14th Feb 2024, 14:20 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback